Spondyloarthropathies in 2010: New insights into therapy-TNF blockade and beyond

Nature Reviews Rheumatology

Volumn 7, Issue 2, 2011, Pages 78-80

  Sieper, Joachim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL DNA; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOXYCYCLINE; ETANERCEPT; PLACEBO; RIFAMPICIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR;

ANKYLOSING SPONDYLITIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG TARGETING; ENTHESITIS; HUMAN; NONHUMAN; OSSIFICATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; REVIEW; SPONDYLOARTHROPATHY;

ANIMALS; ANTIRHEUMATIC AGENTS; CHLAMYDIA INFECTIONS; HUMANS; IMMUNOGLOBULIN G; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; SPONDYLARTHROPATHIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79551699702     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.224     Document Type: Review

References (10)

1. rudwaleit, M. et al. The development of assessment of Spondyloarthritis international Society classification criteria for axial spondyloarthritis (part ii): validation and final selection. Ann. Rheum. Dis. 68, 777-783 (2009).
2. rudwaleit, M. et al. The assessment of Spondyloarthritis international Society (aSaS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann. Rheum. Dis. 70, 25-31 (2011).
3. rudwaleit, M., Khan, M. a. & Sieper, J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 52, 1000-1008 (2005). (Pubitemid 40530105)
4. van der Heijde, D. et al. radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum. 58, 3063-3070 (2008).
5. Sieper, J., appel, H., Braun, J. & rudwaleit, M. Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum. 58, 649-656 (2008). (Pubitemid 351364862)
6. Diarra, D. et al. Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. 13, 156-163 (2007).
7. Uderhardt, S. et al. Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints. Ann. Rheum. Dis. 69, 592-597 (2010).
8. Dougados, M. et al. a randomised, multicenter, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HeeL trial. Ann. Rheum. Dis. 69, 1430-1435 (2010).
9. Carter, J. D. et al. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum. 60, 1311-1316 (2009).
10. Carter, J. D. et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebocontrolled, prospective trial. Arthritis Rheum. 62, 1298-1307 (2010).